In this study 96 15-mer peptides encompassing the entire sequence of HIV-1 gp120 were synthesized and used to immunize BALB/c mice (i) alone or (ii) in conjunction with the T helper cell determinant FISEAIIHVLHSR (FIS) from sperm whale myoglobin, which is well recognized by major histocompatibility complex (MHC) class II molecules of BALB/c. Of these peptides 39 were immunogenic per se and 57 were not. Out of the 57 non-immunogenic peptides 53 could be rendered immunogenic with the second immunization protocol. With the exception of 4 cases, the anti-peptide antibody titers induced in (ii) were equal (14 cases) or higher (78 cases) than those induced in (i). From the 96 anti-peptide antibodies tested, 12 were able to recognize recombinant g...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Contains fulltext : 80770.pdf (publisher's version ) (Closed access)To be effectiv...
A class of synthetic peptide immunogens for the cell surface HIV receptor complex has been developed...
The research presented here is part of an ongoing effort to develop an epitopetargeted vaccine again...
Synthetic peptides were used as tools in order to study various characteristic sof human immunodefic...
Envelope glycoproteins, gp120 and gp41, of the human immunodeficiency virus type 1 (HIV-1) elicit im...
<div><p>Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV....
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
Novel strategies are needed for the elicitation of broadly neutralizing antibodies to the HIV envelo...
The Bridging Sheet domain of HIV-1 gp120 is highly conserved among the HIV-1 strains and allows HIV-...
The Bridging Sheet domain of HIV-1 gp120 is highly conserved among the HIV-1 strains and allows HIV-...
The protein conjugates of two peptides (P1 and P2) with the sequences 101-116 and 253-274 of the hum...
Some conserved glycans on the HIV envelope protein are targets of broadly neutralizing antibodies (b...
Identification of immunodominant T-helper-cell determinants after natural infection is an important ...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Contains fulltext : 80770.pdf (publisher's version ) (Closed access)To be effectiv...
A class of synthetic peptide immunogens for the cell surface HIV receptor complex has been developed...
The research presented here is part of an ongoing effort to develop an epitopetargeted vaccine again...
Synthetic peptides were used as tools in order to study various characteristic sof human immunodefic...
Envelope glycoproteins, gp120 and gp41, of the human immunodeficiency virus type 1 (HIV-1) elicit im...
<div><p>Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV....
Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly ...
Novel strategies are needed for the elicitation of broadly neutralizing antibodies to the HIV envelo...
The Bridging Sheet domain of HIV-1 gp120 is highly conserved among the HIV-1 strains and allows HIV-...
The Bridging Sheet domain of HIV-1 gp120 is highly conserved among the HIV-1 strains and allows HIV-...
The protein conjugates of two peptides (P1 and P2) with the sequences 101-116 and 253-274 of the hum...
Some conserved glycans on the HIV envelope protein are targets of broadly neutralizing antibodies (b...
Identification of immunodominant T-helper-cell determinants after natural infection is an important ...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Cytotoxic T lymphocytes (CTLs) play an important role in the suppression of initial viremia after ac...
Contains fulltext : 80770.pdf (publisher's version ) (Closed access)To be effectiv...